PL2898886T3 - Kompozycja farmaceutyczna do podawania doustnego z polepszoną elucją i/lub wchłanianiem - Google Patents

Kompozycja farmaceutyczna do podawania doustnego z polepszoną elucją i/lub wchłanianiem

Info

Publication number
PL2898886T3
PL2898886T3 PL13839200T PL13839200T PL2898886T3 PL 2898886 T3 PL2898886 T3 PL 2898886T3 PL 13839200 T PL13839200 T PL 13839200T PL 13839200 T PL13839200 T PL 13839200T PL 2898886 T3 PL2898886 T3 PL 2898886T3
Authority
PL
Poland
Prior art keywords
absorbency
pharmaceutical composition
oral administration
improved elution
elution
Prior art date
Application number
PL13839200T
Other languages
English (en)
Inventor
Takashi Suefuji
Original Assignee
Taiho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co., Ltd. filed Critical Taiho Pharmaceutical Co., Ltd.
Publication of PL2898886T3 publication Critical patent/PL2898886T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PL13839200T 2012-09-19 2013-09-18 Kompozycja farmaceutyczna do podawania doustnego z polepszoną elucją i/lub wchłanianiem PL2898886T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012205681 2012-09-19
EP13839200.6A EP2898886B1 (en) 2012-09-19 2013-09-18 Pharmaceutical composition for oral administration with improved elution and/or absorbency

Publications (1)

Publication Number Publication Date
PL2898886T3 true PL2898886T3 (pl) 2017-06-30

Family

ID=50341439

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13839200T PL2898886T3 (pl) 2012-09-19 2013-09-18 Kompozycja farmaceutyczna do podawania doustnego z polepszoną elucją i/lub wchłanianiem

Country Status (19)

Country Link
US (1) US9555115B2 (pl)
EP (1) EP2898886B1 (pl)
JP (1) JP5791817B2 (pl)
KR (1) KR101609105B1 (pl)
CN (1) CN104640547B (pl)
AU (1) AU2013319118B2 (pl)
BR (1) BR112015005489B1 (pl)
CA (1) CA2884731C (pl)
DK (1) DK2898886T3 (pl)
ES (1) ES2622585T3 (pl)
HU (1) HUE032635T2 (pl)
MX (1) MX345435B (pl)
MY (1) MY183976A (pl)
PL (1) PL2898886T3 (pl)
PT (1) PT2898886T (pl)
RU (1) RU2589701C1 (pl)
SG (1) SG11201501043TA (pl)
TW (1) TWI536992B (pl)
WO (1) WO2014046129A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI707851B (zh) * 2015-09-17 2020-10-21 日商大鵬藥品工業股份有限公司 哌嗪化合物的新穎結晶

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
TW482675B (en) * 1997-01-31 2002-04-11 Green Cross Corp Compositions for oral administration containing pyridazinone compounds technical field of the invention
JP4292588B2 (ja) * 1997-01-31 2009-07-08 日産化学工業株式会社 ピリダジノン化合物類の経口製剤
JP3797764B2 (ja) 1997-10-01 2006-07-19 エーザイ株式会社 光安定化組成物
AU2002255452B2 (en) * 2000-12-21 2006-06-08 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6890918B2 (en) 2001-04-30 2005-05-10 Shire Laboratories, Inc. Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers
US20040137052A1 (en) 2001-12-25 2004-07-15 Yoshihiro Uchiyama Acid-containing preparations
JP2003252762A (ja) * 2001-12-25 2003-09-10 Takeda Chem Ind Ltd 酸配合製剤
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
DE10337697A1 (de) 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
JP4572293B2 (ja) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
BRPI0716196A2 (pt) * 2006-08-31 2013-11-12 Eurand Inc Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.
CA2681143C (en) 2007-03-28 2017-01-03 Takeda Pharmaceutical Company Limited Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
KR101520311B1 (ko) 2007-05-21 2015-05-14 도레이 카부시키가이샤 특정 유기산을 함유하는 경구 제제, 및 경구 제제의 용출성과 화학적 안정성의 개선 방법
US20110275637A1 (en) 2008-06-04 2011-11-10 Emma Chapman Piperazine derivatives and their use as leptin receptor modulators
SG186685A1 (en) 2008-07-28 2013-01-30 Takeda Pharmaceutical Pharmaceutical composition
DE112009005027B4 (de) 2009-03-06 2018-07-19 Toyota Jidosha Kabushiki Kaisha Fahrzeugantriebsunterstützungsvorrichtung
DK2407466T3 (en) * 2009-03-09 2016-03-07 Taiho Pharmaceutical Co Ltd Piperazine WHO IS ABLE TO INHIBIT prostaglandin D synthase

Also Published As

Publication number Publication date
JP5791817B2 (ja) 2015-10-07
MX2015003410A (es) 2015-06-04
MY183976A (en) 2021-03-17
BR112015005489B1 (pt) 2022-07-12
HK1207969A1 (en) 2016-02-19
EP2898886B1 (en) 2017-02-15
US9555115B2 (en) 2017-01-31
KR101609105B1 (ko) 2016-04-04
CA2884731A1 (en) 2014-03-27
CA2884731C (en) 2016-11-01
DK2898886T3 (en) 2017-03-27
PT2898886T (pt) 2017-03-23
TWI536992B (zh) 2016-06-11
JPWO2014046129A1 (ja) 2016-08-18
EP2898886A4 (en) 2016-04-27
MX345435B (es) 2017-01-30
ES2622585T3 (es) 2017-07-06
HUE032635T2 (en) 2017-10-30
AU2013319118A1 (en) 2015-03-12
TW201414476A (zh) 2014-04-16
KR20150056827A (ko) 2015-05-27
BR112015005489A2 (pt) 2017-07-04
SG11201501043TA (en) 2015-04-29
EP2898886A1 (en) 2015-07-29
AU2013319118B2 (en) 2016-03-03
CN104640547A (zh) 2015-05-20
RU2589701C1 (ru) 2016-07-10
US20150297722A1 (en) 2015-10-22
CN104640547B (zh) 2017-07-11
WO2014046129A1 (ja) 2014-03-27

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
ZA201406233B (en) Pharmaceutical composition and administration thereof
IL236024A (en) The history of benzimidazole-proline and its pharmaceutical preparations
SG11201403875VA (en) Oral pharmaceutical composition
ZA201306395B (en) New low side effect pharmaceutical composition containing antituberculosis drugs
ZA201409508B (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
GB2504390B (en) Nutraceutical and pharmaceutical composition
ZA201302012B (en) Low dose pharmaceutical composition
ZA201504512B (en) Pharmaceutical composition comprising desloratadine and prednisolone and use thereof
IL235947A0 (en) History of isonicotinamide in solid state and pharmaceutical preparations containing them
ZA201400340B (en) Pharmaceutical composition comprising ebastine and fluticasone
PT2415463E (pt) Composição medicinal em partículas
PT2898886T (pt) Composição farmacêutica para administração oral apresentando uma melhor eluição e/ou uma melhor capacidade de absorção
EP2979698A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
EP2529755A4 (en) PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION
IL233983A0 (en) History of thiazolidinones, their preparation and pharmaceutical preparations containing them
IL234614B (en) Pharmaceutical composition and preparation method thereof
GB201112578D0 (en) Pharmaceutical preparation and use